Document is current
Any future updates will be listed below
-
Authors
Trief, Paula M. https://orcid.org/0000-0002-2827-5722
Wen, Hui https://orcid.org/0000-0002-0597-7596
Anderson, Barbara J. https://orcid.org/0000-0003-1587-7967
Burke, Brian https://orcid.org/0000-0002-1618-2780
Bulger, Jane https://orcid.org/0000-0002-3585-4896
Weinstock, Ruth S. https://orcid.org/0000-0001-5859-5666
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (RO1DK110456)
- License Information
-
More Information
Article History
Received: 16 September 2024
Accepted: 23 January 2025
First Online: 5 March 2025
Declarations
:
: All procedures performed in this study were in accordance with the ethical standards of the 1964 Helsinki Declaration and its later amendments. TODAY, TODAY2 and iCount were approved by institutional review boards at 15 participating centers (IRB approval #1032847 at the primary institution).
: Informed consent was obtained from all participants in the study. The study involved independent data collection and access to data from the TODAY2 assessments, defined during the informed consent process, and detailed in a signed informed consent document.
: Not applicable.
: Dr Trief reports grants from National Institutes of Health during the conduct of the study, and serves on the Editorial Board of the Journal of Behavioral Medicine. Dr. Anderson reports grants from National Institutes of Health and the Leona M. and Harry B. Helmsley Charitable Trust during the conduct of the study. Dr. Weinstock reports participation in multicenter clinical trials through her institution, sponsored by: Eli Lilly, Insulet, Tandem, Amgen, Diasome, and MannKind. Ms. Wen, Mr. Burke and Ms. Bulger have nothing to disclose.
